AIP
EVLO

Ameritas Investment Partners’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Ameritas Investment Partners’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-119
Closed -$8K – 3324
2022
Q1 		$8K Hold
119
– – ﹤0.01% 2875
2021
Q4 		$14K Hold
119
– – ﹤0.01% 2804
2021
Q3 		$17K Hold
119
– – ﹤0.01% 2791
2021
Q2 		$33K Buy
119
+35
+42% +$8.83K ﹤0.01% 2458
2021
Q1 		$18K Buy
84
+27
+47% +$7.46K ﹤0.01% 2619
2020
Q4 		$14K Hold
57
– – ﹤0.01% 2662
2020
Q3 		$6K Hold
57
– – ﹤0.01% 2948
2020
Q2 		$6K Hold
57
– – ﹤0.01% 2935
2020
Q1 		$4K Hold
57
– – ﹤0.01% 2883
2019
Q4 		$5K Hold
57
– – ﹤0.01% 2908
2019
Q3 		$7K Hold
57
– – ﹤0.01% 2869
2019
Q2 		$10K Hold
57
– – ﹤0.01% 2814
2019
Q1 		$9K Buy
57
+38
+200% +$7.52K ﹤0.01% 2743
2018
Q4 		$5K Hold
19
– – ﹤0.01% 2867
2018
Q3 		$5K Hold
19
– – ﹤0.01% 2955
2018
Q2 		$4K Buy
+19
New +$5.54K ﹤0.01% 2960

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's EVLO Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 119 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in EVLO in Q2 2018 and held it in 16 quarters. The position peaked at $33K in Q2 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

  • Ameritas Investment Partners reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 119 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $8K.
  • Ameritas Investment Partners first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
  • Ameritas Investment Partners's Evelo Biosciences, Inc. Common Stock position peaked at $33K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.